340: Crisis in CRISPR world, RFK Jr.'s promises, and a novel non-opioid pain drug
The Readout Loud
00:00
Intro
The hosts introduce key themes around the CRISPR gene editing industry, addressing its challenges and future prospects. They highlight recent earnings reports, significant political votes, and breakthroughs in biotechnology, setting the stage for an in-depth discussion.
Transcript
Play full episode
